Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Indivior appoints Ryan Preblick as CFO

Fri, 20th Nov 2020 11:34

(Sharecast News) - Indivior has appointed Ryan Preblick as chief financial officer after he spent five months in the job on an interim basis.
Preblick has had senior finance jobs at the prescription drugs company since joining in 2012. He takes over from Mark Crossley who stepped up to become chief executive in June.

Before standing in as CFO Preblick was Indivior's senior vice president of global financial planning for commercial operations. Indivior said that job included overseeing financial management, analysis and reporting of the group's global business.

Preblick's appointment puts a new senior team in place after turbulence caused by a long-running legal case in the US over fraudulent marketing of Indivior's opioid addiction treatment. Shaun Thaxter stood down as CEO in June and was sent to jail for six months after pleading guilty to a criminal charge related to sales of the Suboxone treatment.

Crossley said: "Ryan has proven to be a highly capable leader of our finance organisation and has performed strongly in his role as interim chief financial officer. The board and I are delighted to confirm his appointment as chief financial officer and executive director."

Indivior agreed in July to pay the US Department of Justice and other authorities $600m over seven years and plead guilty to a felony charge to settle the Suboxone case. A federal court approved the agreement on 13 November, drawing a line under a matter that has hung over the company for most of the time since it split from Reckitt Benckiser in 2014.

Preblick started his career in corporate finance at Honeywell International and then worked for 12 years at cigarette company Altria.

Related Shares

More News
23 May 2024 12:29

IN BRIEF: Indivior reconfirms 2024 outlook amid NY-listing decision

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Reconfirms financial guidance for 2024 ahead of analyst 'teach-in' event in...

16 May 2024 15:46

UK shareholder meetings calendar - next 7 days

3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

2 May 2024 13:48

UK shareholder meetings calendar - next 7 days

25 Apr 2024 09:23

Indivior shares down despite profit boost on planned shift to New York

(Alliance News) - Indivior PLC on Thursday saw its shares fall despite reporting a quarterly uptick in profit, as it announced plans to switch its lis...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.